🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Death Mechanisms of Pulmonary Alveolocytes in Mice Infected with Influenza Viruses A/H1N1/California/04/2009 and A/H5N1/Goose/Krasnoozerskoye/627/05


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In CBA mice infected with influenza viruses A/H1N1/California/04/2009 and A/H5N1/Goose/Krasnoozerskoye/627/05 in a dose of 10 MLD50, the mechanisms of death of pulmonary alveolocytes over 10 postinfection days were studied by light microscopy, immunohistochemistry, and morphometry. In mice infected with A/H1N1, alveolocytes died predominantly via necrosis, while apoptosis mostly employed the mitochondrial pathway. In mice infected with A/H5N1, apoptosis was the dominant mechanism of alveolocyte death proceeded via membrane receptor signaling followed by switching to FAS-mediated pathway via activation of FADD, the apoptotic signal transduction protein.

About the authors

T. V. Sharkova

Optimum Medical Laboratory, Research-and-Educational Center

Email: cherdanceff@yandex.ru
Russian Federation, Sochi

V. A. Shkurupy

Research Institute of Experimental and Clinical Medicine, Federal Research Center of Fundamental and Translational Medicine; Novosibirsk State Medical University

Email: cherdanceff@yandex.ru
Russian Federation, Novosibirsk; Novosibirsk

A. M. Shestopalov

Research Institute of Experimental and Clinical Medicine, Federal Research Center of Fundamental and Translational Medicine

Email: cherdanceff@yandex.ru
Russian Federation, Novosibirsk

O. V. Potapova

Optimum Medical Laboratory, Research-and-Educational Center

Email: cherdanceff@yandex.ru
Russian Federation, Sochi

L. A. Cherdantseva

Research Institute of Experimental and Clinical Medicine, Federal Research Center of Fundamental and Translational Medicine

Author for correspondence.
Email: cherdanceff@yandex.ru
Russian Federation, Novosibirsk

A. V. Kovner

Research Institute of Experimental and Clinical Medicine, Federal Research Center of Fundamental and Translational Medicine

Email: cherdanceff@yandex.ru
Russian Federation, Novosibirsk

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature